Dr.-Ing. Thomas Wucherpfennig

Boehringer Ingelheim Pharma GmbH & Co. KG
Bioprocess Development Biologicals

Binger Strasse 173

55216 Ingelheim am Rhein

Phone +49 7351 54-144806

Mail Dr. Thomas Wucherpfennig


Thomas pursued the study of Biotechnology at the Technical University of Braunschweig, Germany, and Chemical Engineering at the University of Waterloo, Canada. He earned his PhD in Bioprocess Engineering from the Technical University of Braunschweig. Prior to joining Boehringer Ingelheim as a postdoctoral fellow in 2014, Thomas acquired valuable experience in the industrial biotech sector at Roche and Clariant. Since 2015, he has held various roles in cell culture process development at Boehringer Ingelheim and currently serves as a Senior Principal Scientist, spearheading late-stage process development. In addition, Thomas is a lecturer at FH Oberösterreich in Wels and TUHH – Hamburg University of Technology, His research focus is on bioprocess scale-up, bioreactor characterization, Process Analytical Technology (PAT), and cell culture process modeling.

Research Interests

  • Scale-up of bioprocesses
  • Bioreactor characterization
  • Computational Fluid Dynamics (CFD)
  • Process Analytical Technology (PAT)
  • Cell culture process modelling

Publications

[185000]
Title: CFD supported scale up of perfusion bioreactors in biopharma.
Written by: M. Kuschel, J. Wutz, M. Salli, D. Monteil, T. Wucherpfennig
in: <em>Frontiers in Chemical Engineering</em>. (2023).
Volume: <strong>5</strong>. Number: (3),
on pages:
Chapter:
Editor:
Publisher:
Series:
Address:
Edition:
ISBN:
how published:
Organization:
School:
Institution:
Type:
DOI: https://doi.org/10.3389/fceng.2023.1076509
URL:
ARXIVID:
PMID:

Note:

Abstract: The robust scale up of perfusion systems requires comparable conditions over all scales to ensure equivalent cell culture performance. As cells in continuous processes circulate outside the bioreactor, performance losses may arise if jet flow and stirring cause a direct connection between perfusion feed and return. Computational fluid dynamics can be used to identify such short circuit flows, assess mixing efficiencies, and eventually adapt the perfusion setup. This study investigates the scale up from a 2 L glass bioreactor to 100 L and 500 L disposable pilot scale systems. Highly resolved Lattice Boltzmann Large Eddy simulations were performed in single phase and mixing efficiencies (Emix) furthermore experimentally validated in the 2 L system. This evaluation gives insight into the flow pattern, the mixing behavior and information on cell residence time inside the bioreactors. No geometric adaptations in the pilot scale systems were necessary as Emix was greater than 90% for all conditions tested. Two different setups were evaluated in 2 L scale where the direction of flow was changed, yielding a difference in mixing efficiency of 10%. Nevertheless, since Emix was confirmed to be >90% also for both 2 L setups and the determined mixing times were in a similar range for all scales, the 2 L system was deemed to be a suitable scale down model. The results demonstrate how computational fluid dynamic models can be used for rational process design of intensified production processes in the biopharmaceutical industry.